<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32093728</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>19</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1750-1326</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Feb</Month><Day>24</Day></PubDate></JournalIssue><Title>Molecular neurodegeneration</Title><ISOAbbreviation>Mol Neurodegener</ISOAbbreviation></Journal><ArticleTitle>Dipeptide repeat proteins inhibit homology-directed DNA double strand break repair in C9ORF72 ALS/FTD.</ArticleTitle><Pagination><StartPage>13</StartPage><MedlinePgn>13</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">13</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13024-020-00365-9</ELocationID><Abstract><AbstractText Label="BACKGROUND">The C9ORF72 hexanucleotide repeat expansion is the most common known genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), two fatal age-related neurodegenerative diseases. The C9ORF72 expansion encodes five dipeptide repeat proteins (DPRs) that are produced through a non-canonical translation mechanism. Among the DPRs, proline-arginine (PR), glycine-arginine (GR), and glycine-alanine (GA) are the most neurotoxic and increase the frequency of DNA double strand breaks (DSBs). While the accumulation of these genotoxic lesions is increasingly recognized as a feature of disease, the mechanism(s) of DPR-mediated DNA damage are ill-defined and the effect of DPRs on the efficiency of each DNA DSB repair pathways has not been previously evaluated.</AbstractText><AbstractText Label="METHODS AND RESULTS">Using DNA DSB repair assays, we evaluated the efficiency of specific repair pathways, and found that PR, GR and GA decrease the efficiency of non-homologous end joining (NHEJ), single strand annealing (SSA), and microhomology-mediated end joining (MMEJ), but not homologous recombination (HR). We found that PR inhibits DNA DSB repair, in part, by binding to the nucleolar protein nucleophosmin (NPM1). Depletion of NPM1 inhibited NHEJ and SSA, suggesting that NPM1 loss-of-function in PR expressing cells leads to impediments of both non-homologous and homology-directed DNA DSB repair pathways. By deleting NPM1 sub-cellular localization signals, we found that PR binds NPM1 regardless of the cellular compartment to which NPM1 was directed. Deletion of the NPM1 acidic loop motif, known to engage other arginine-rich proteins, abrogated PR and NPM1 binding. Using confocal and super-resolution immunofluorescence microscopy, we found that levels of RAD52, a component of the SSA repair machinery, were significantly increased iPSC neurons relative to isogenic controls in which the C9ORF72 expansion had been deleted using CRISPR/Cas9 genome editing. Western analysis of post-mortem brain tissues confirmed that RAD52 immunoreactivity is significantly increased in C9ALS/FTD samples as compared to controls.</AbstractText><AbstractText Label="CONCLUSIONS">Collectively, we characterized the inhibitory effects of DPRs on key DNA DSB repair pathways, identified NPM1 as a facilitator of DNA repair that is inhibited by PR, and revealed deficits in homology-directed DNA DSB repair pathways as a novel feature of C9ORF72-related disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Andrade</LastName><ForeName>Nadja S</ForeName><Initials>NS</Initials><AffiliationInfo><Affiliation>Department of Psychiatry &amp; Behavioral Sciences, Center for Therapeutic Innovation, University of Miami Miller School of Medicine, 1501 NW 10th Ave, Biomedical Research Building Room 413, Florida, Miami, 33136, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramic</LastName><ForeName>Melina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Psychiatry &amp; Behavioral Sciences, Center for Therapeutic Innovation, University of Miami Miller School of Medicine, 1501 NW 10th Ave, Biomedical Research Building Room 413, Florida, Miami, 33136, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Esanov</LastName><ForeName>Rustam</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Psychiatry &amp; Behavioral Sciences, Center for Therapeutic Innovation, University of Miami Miller School of Medicine, 1501 NW 10th Ave, Biomedical Research Building Room 413, Florida, Miami, 33136, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Wenjun</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, 1600 NW 10th Ave, Miami, FL, 33136, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rybin</LastName><ForeName>Mathew J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Psychiatry &amp; Behavioral Sciences, Center for Therapeutic Innovation, University of Miami Miller School of Medicine, 1501 NW 10th Ave, Biomedical Research Building Room 413, Florida, Miami, 33136, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gaidosh</LastName><ForeName>Gabriel</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>John P Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, 1501 NW 10th Ave, Miami, FL, 33136, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sylvester Comprehensive Cancer Center, Biomedical Research Building, 1501 NW 10th Avenue, Miami, FL, 33136, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdallah</LastName><ForeName>Abbas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Massachusetts Medical School, Worchester, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Del'Olio</LastName><ForeName>Samuel</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Psychiatry &amp; Behavioral Sciences, Center for Therapeutic Innovation, University of Miami Miller School of Medicine, 1501 NW 10th Ave, Biomedical Research Building Room 413, Florida, Miami, 33136, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huff</LastName><ForeName>Tyler C</ForeName><Initials>TC</Initials><AffiliationInfo><Affiliation>John P Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, 1501 NW 10th Ave, Miami, FL, 33136, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dr. John T Macdonald Foundation Department of Human Genetics, University of Miami Miller School of Medicine, 1601 NW 12th Ave, Miami, FL., 33136, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chee</LastName><ForeName>Nancy T</ForeName><Initials>NT</Initials><AffiliationInfo><Affiliation>Department of Psychiatry &amp; Behavioral Sciences, Center for Therapeutic Innovation, University of Miami Miller School of Medicine, 1501 NW 10th Ave, Biomedical Research Building Room 413, Florida, Miami, 33136, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anatha</LastName><ForeName>Sadhana</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Psychiatry &amp; Behavioral Sciences, Center for Therapeutic Innovation, University of Miami Miller School of Medicine, 1501 NW 10th Ave, Biomedical Research Building Room 413, Florida, Miami, 33136, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gendron</LastName><ForeName>Tania F</ForeName><Initials>TF</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Mayo Clinic, 4500 San Pablo Rd, Jacksonville, FL, 32224, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wahlestedt</LastName><ForeName>Claes</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Psychiatry &amp; Behavioral Sciences, Center for Therapeutic Innovation, University of Miami Miller School of Medicine, 1501 NW 10th Ave, Biomedical Research Building Room 413, Florida, Miami, 33136, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yanbin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, 1600 NW 10th Ave, Miami, FL, 33136, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benatar</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Miami Miller School of Medicine, 115 NW 14th St.,, Miami, FL, 33136, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mueller</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Massachusetts Medical School, Worchester, MA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics and Horae Gene Therapy Center, University of Massachusetts Medical School, Worcester, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeier</LastName><ForeName>Zane</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Psychiatry &amp; Behavioral Sciences, Center for Therapeutic Innovation, University of Miami Miller School of Medicine, 1501 NW 10th Ave, Biomedical Research Building Room 413, Florida, Miami, 33136, USA. zzeier@med.miami.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R21 NS102829</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS088689</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 NS090291</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>02</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Mol Neurodegener</MedlineTA><NlmUniqueID>101266600</NlmUniqueID><ISSNLinking>1750-1326</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C568651">C9orf72 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004151">Dipeptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000716967">NPM1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009687">Nuclear Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>117896-08-9</RegistryNumber><NameOfSubstance UI="D000090243">Nucleophosmin</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C566288">Frontotemporal Dementia With Motor Neuron Disease</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053903" MajorTopicYN="Y">DNA Breaks, Double-Stranded</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004260" MajorTopicYN="N">DNA Repair</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042622" MajorTopicYN="N">DNA Repeat Expansion</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004151" MajorTopicYN="N">Dipeptides</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="N">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009687" MajorTopicYN="N">Nuclear Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000090243" MajorTopicYN="N">Nucleophosmin</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">CRISPR</Keyword><Keyword MajorTopicYN="N">DNA damage</Keyword><Keyword MajorTopicYN="N">DNA double strand break repair</Keyword><Keyword MajorTopicYN="N">Homology-directed repair</Keyword><Keyword MajorTopicYN="N">Induced pluripotent stem cells</Keyword><Keyword MajorTopicYN="N">RAD52</Keyword><Keyword MajorTopicYN="N">Single-strand annealing</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>7</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>2</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32093728</ArticleId><ArticleId IdType="pmc">PMC7041170</ArticleId><ArticleId IdType="doi">10.1186/s13024-020-00365-9</ArticleId><ArticleId IdType="pii">10.1186/s13024-020-00365-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Al-Chalabi A, Jones A, Troakes C, King A, Al-Sarraj S, van den Berg LH. The genetics and neuropathology of amyotrophic lateral sclerosis. Acta Neuropathol. 2012;124(3):339&#x2013;352. doi: 10.1007/s00401-012-1022-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-012-1022-4</ArticleId><ArticleId IdType="pubmed">22903397</ArticleId></ArticleIdList></Reference><Reference><Citation>Burrell James R, Halliday Glenda M, Kril Jillian J, Ittner Lars M, G&#xf6;tz J&#xfc;rgen, Kiernan Matthew C, Hodges John R. The frontotemporal dementia-motor neuron disease continuum. The Lancet. 2016;388(10047):919&#x2013;931. doi: 10.1016/S0140-6736(16)00737-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(16)00737-6</ArticleId><ArticleId IdType="pubmed">26987909</ArticleId></ArticleIdList></Reference><Reference><Citation>Majounie E, Renton AE, Mok K, et al. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol. 2012;11(4):323&#x2013;330. doi: 10.1016/S1474-4422(12)70043-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(12)70043-1</ArticleId><ArticleId IdType="pmc">PMC3322422</ArticleId><ArticleId IdType="pubmed">22406228</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, Lin S, Staats KA, et al. Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons. Nat Med. 2018;24(3):313&#x2013;325. doi: 10.1038/nm.4490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4490</ArticleId><ArticleId IdType="pmc">PMC6112156</ArticleId><ArticleId IdType="pubmed">29400714</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendron Tania F., Petrucelli Leonard. Disease Mechanisms of C9ORF72 Repeat Expansions. Cold Spring Harbor Perspectives in Medicine. 2017;8(4):a024224. doi: 10.1101/cshperspect.a024224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a024224</ArticleId><ArticleId IdType="pmc">PMC5880161</ArticleId><ArticleId IdType="pubmed">28130314</ArticleId></ArticleIdList></Reference><Reference><Citation>Haeusler AR, Donnelly CJ, Rothstein JD. The expanding biology of the C9orf72 nucleotide repeat expansion in neurodegenerative disease. Nat Rev Neurosci. 2016;17(6):383&#x2013;395. doi: 10.1038/nrn.2016.38.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn.2016.38</ArticleId><ArticleId IdType="pmc">PMC7376590</ArticleId><ArticleId IdType="pubmed">27150398</ArticleId></ArticleIdList></Reference><Reference><Citation>Haeusler AR, Donnelly CJ, Periz G, et al. C9orf72 nucleotide repeat structures initiate molecular cascades of disease. Nature. 2014;507(7491):195&#x2013;200. doi: 10.1038/nature13124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature13124</ArticleId><ArticleId IdType="pmc">PMC4046618</ArticleId><ArticleId IdType="pubmed">24598541</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum BD, Taylor JP. The role of dipeptide repeats in C9ORF72-related ALS-FTD. Front Mol Neurosci. 2017;10:35. doi: 10.3389/fnmol.2017.00035.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00035</ArticleId><ArticleId IdType="pmc">PMC5303742</ArticleId><ArticleId IdType="pubmed">28243191</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao Z, Wang H, Xia Q, et al. Nucleolar stress and impaired stress granule formation contribute to C9orf72 RAN translation-induced cytotoxicity. Hum Mol Genet. 2015;24(9):2426&#x2013;2441. doi: 10.1093/hmg/ddv005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddv005</ArticleId><ArticleId IdType="pubmed">25575510</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon I, Xiang S, Kato M, et al. Poly-dipeptides encoded by the C9orf72 repeats bind nucleoli, impede RNA biogenesis, and kill cells. Science. 2014;345(6201):1139&#x2013;1145. doi: 10.1126/science.1254917.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1254917</ArticleId><ArticleId IdType="pmc">PMC4459787</ArticleId><ArticleId IdType="pubmed">25081482</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamakawa M, Ito D, Honda T, et al. Characterization of the dipeptide repeat protein in the molecular pathogenesis of c9FTD/ALS. Hum Mol Genet. 2015;24(6):1630&#x2013;1645. doi: 10.1093/hmg/ddu576.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu576</ArticleId><ArticleId IdType="pubmed">25398948</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizielinska S, Ridler CE, Balendra R, et al. Bidirectional nucleolar dysfunction in C9orf72 frontotemporal lobar degeneration. Acta Neuropathol Commun. 2017;5(1):29. doi: 10.1186/s40478-017-0432-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-017-0432-x</ArticleId><ArticleId IdType="pmc">PMC5395972</ArticleId><ArticleId IdType="pubmed">28420437</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrmann D, Parlato R. C9orf72-associated neurodegeneration in ALS-FTD: breaking new ground in ribosomal RNA and nucleolar dysfunction. Cell Tissue Res. 2018.</Citation><ArticleIdList><ArticleId IdType="pubmed">29450726</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran H, Almeida S, Moore J, et al. Differential toxicity of nuclear RNA foci versus dipeptide repeat proteins in a Drosophila model of C9ORF72 FTD/ALS. Neuron. 2015;87(6):1207&#x2013;1214. doi: 10.1016/j.neuron.2015.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.09.015</ArticleId><ArticleId IdType="pmc">PMC4589299</ArticleId><ArticleId IdType="pubmed">26402604</ArticleId></ArticleIdList></Reference><Reference><Citation>Schludi MH, May S, Gr&#xe4;sser FA, et al. Distribution of dipeptide repeat proteins in cellular models and C9orf72 mutation cases suggests link to transcriptional silencing. Acta Neuropathol. 2015;130(4):537&#x2013;555. doi: 10.1007/s00401-015-1450-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1450-z</ArticleId><ArticleId IdType="pmc">PMC4575390</ArticleId><ArticleId IdType="pubmed">26085200</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee KH, Zhang P, Kim HJ, et al. C9orf72 dipeptide repeats impair the assembly, dynamics, and function of membrane-less organelles. Cell. 2016;167(3):774&#x2013;788. doi: 10.1016/j.cell.2016.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.10.002</ArticleId><ArticleId IdType="pmc">PMC5079111</ArticleId><ArticleId IdType="pubmed">27768896</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y, Mori E, Kato M, et al. Toxic PR poly-dipeptides encoded by the C9orf72 repeat expansion target LC domain polymers. Cell. 2016;167(3):789&#x2013;802. doi: 10.1016/j.cell.2016.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.10.003</ArticleId><ArticleId IdType="pmc">PMC5076566</ArticleId><ArticleId IdType="pubmed">27768897</ArticleId></ArticleIdList></Reference><Reference><Citation>Brangwynne Clifford P, Tompa P, Pappu RV. Polymer physics of intracellular phase transitions. Nat Phys. 2015;11(11):899&#x2013;904. doi: 10.1038/nphys3532.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nphys3532</ArticleId></ArticleIdList></Reference><Reference><Citation>Fratta P, Mizielinska S, Nicoll AJ, et al. C9orf72 hexanucleotide repeat associated with amyotrophic lateral sclerosis and frontotemporal dementia forms RNA G-quadruplexes. Sci Rep. 2012;2:1016. doi: 10.1038/srep01016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep01016</ArticleId><ArticleId IdType="pmc">PMC3527825</ArticleId><ArticleId IdType="pubmed">23264878</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy K, Zamiri B, Stanley SY, Macgregor RB, Jr, Pearson CE. The disease-associated r(GGGGCC)n repeat from the C9orf72 gene forms tract length-dependent uni- and multimolecular RNA G-quadruplex structures. J Biol Chem. 2013;288(14):9860&#x2013;9866. doi: 10.1074/jbc.C113.452532.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.C113.452532</ArticleId><ArticleId IdType="pmc">PMC3617286</ArticleId><ArticleId IdType="pubmed">23423380</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J, Higginbottom A, Stopford MJ, et al. Antisense RNA foci in the motor neurons of C9ORF72-ALS patients are associated with TDP-43 proteinopathy. Acta Neuropathol. 2015;130(1):63&#x2013;75. doi: 10.1007/s00401-015-1429-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1429-9</ArticleId><ArticleId IdType="pmc">PMC4468790</ArticleId><ArticleId IdType="pubmed">25943887</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen X, Tan W, Westergard T, et al. Antisense proline-arginine RAN dipeptides linked to C9ORF72-ALS/FTD form toxic nuclear aggregates that initiate in vitro and in vivo neuronal death. Neuron. 2014;84(6):1213&#x2013;1225. doi: 10.1016/j.neuron.2014.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.12.010</ArticleId><ArticleId IdType="pmc">PMC4632245</ArticleId><ArticleId IdType="pubmed">25521377</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Rourke JG, Bogdanik L, Muhammad AK, et al. C9orf72 BAC transgenic mice display typical pathologic features of ALS/FTD. Neuron. 2015;88(5):892&#x2013;901. doi: 10.1016/j.neuron.2015.10.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.10.027</ArticleId><ArticleId IdType="pmc">PMC4672384</ArticleId><ArticleId IdType="pubmed">26637796</ArticleId></ArticleIdList></Reference><Reference><Citation>Boulon S, Westman BJ, Hutten S, Boisvert FM, Lamond AI. The nucleolus under stress. Mol Cell. 2010;40(2):216&#x2013;227. doi: 10.1016/j.molcel.2010.09.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2010.09.024</ArticleId><ArticleId IdType="pmc">PMC2987465</ArticleId><ArticleId IdType="pubmed">20965417</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw PJ. Nucleolus. 2005.</Citation></Reference><Reference><Citation>Mizielinska S, Gronke S, Niccoli T, et al. C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins. Science. 2014;345(6201):1192&#x2013;1194. doi: 10.1126/science.1256800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1256800</ArticleId><ArticleId IdType="pmc">PMC4944841</ArticleId><ArticleId IdType="pubmed">25103406</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindstrom MS. NPM1/B23: a multifunctional chaperone in ribosome biogenesis and chromatin remodeling. Biochem Res Int. 2011;2011:195209. doi: 10.1155/2011/195209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2011/195209</ArticleId><ArticleId IdType="pmc">PMC2989734</ArticleId><ArticleId IdType="pubmed">21152184</ArticleId></ArticleIdList></Reference><Reference><Citation>Falini B., Nicoletti I., Bolli N., Martelli M. P., Liso A., Gorello P., Mandelli F., Mecucci C., Martelli M. F. Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias. Haematologica. 2007;92(4):519&#x2013;532. doi: 10.3324/haematol.11007.</Citation><ArticleIdList><ArticleId IdType="doi">10.3324/haematol.11007</ArticleId><ArticleId IdType="pubmed">17488663</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori K, Weng S-M, Arzberger T, et al. The &amp;lt;em&amp;gt;C9orf72&amp;lt;/em&amp;gt; GGGGCC Repeat Is Translated into Aggregating Dipeptide-Repeat Proteins in FTLD/ALS. Science. 2013;339(6125):1335. doi: 10.1126/science.1232927.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1232927</ArticleId><ArticleId IdType="pubmed">23393093</ArticleId></ArticleIdList></Reference><Reference><Citation>Jovicic A, Mertens J, Boeynaems S, et al. Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS. Nat Neurosci. 2015;18(9):1226&#x2013;1229. doi: 10.1038/nn.4085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4085</ArticleId><ArticleId IdType="pmc">PMC4552077</ArticleId><ArticleId IdType="pubmed">26308983</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K, Donnelly CJ, Haeusler AR, et al. The C9orf72 repeat expansion disrupts nucleocytoplasmic transport. Nature. 2015;525(7567):56&#x2013;61. doi: 10.1038/nature14973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14973</ArticleId><ArticleId IdType="pmc">PMC4800742</ArticleId><ArticleId IdType="pubmed">26308891</ArticleId></ArticleIdList></Reference><Reference><Citation>Hisaoka M, Nagata K, Okuwaki M. Intrinsically disordered regions of nucleophosmin/B23 regulate its RNA binding activity through their inter- and intra-molecular association. Nucleic Acids Res. 2014;42(2):1180&#x2013;1195. doi: 10.1093/nar/gkt897.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkt897</ArticleId><ArticleId IdType="pmc">PMC3902904</ArticleId><ArticleId IdType="pubmed">24106084</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfister JA, D'Mello SR. Insights into the regulation of neuronal viability by nucleophosmin/B23. Exp Biol Med (Maywood) 2015;240(6):774&#x2013;786. doi: 10.1177/1535370215579168.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1535370215579168</ArticleId><ArticleId IdType="pmc">PMC4640450</ArticleId><ArticleId IdType="pubmed">25908633</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertwistle D, Sugimoto M, Sherr CJ. Physical and functional interactions of the Arf tumor suppressor protein with Nucleophosmin/B23. Mol Cell Biol. 2004;24(3):985&#x2013;996. doi: 10.1128/MCB.24.3.985-996.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.24.3.985-996.2004</ArticleId><ArticleId IdType="pmc">PMC321449</ArticleId><ArticleId IdType="pubmed">14729947</ArticleId></ArticleIdList></Reference><Reference><Citation>Box JK, Paquet N, Adams MN, et al. Nucleophosmin: from structure and function to disease development. BMC Mol Biol. 2016;17(1):19. doi: 10.1186/s12867-016-0073-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12867-016-0073-9</ArticleId><ArticleId IdType="pmc">PMC4995807</ArticleId><ArticleId IdType="pubmed">27553022</ArticleId></ArticleIdList></Reference><Reference><Citation>Konopka A, Atkin JD. The emerging role of DNA damage in the pathogenesis of the C9orf72 repeat expansion in amyotrophic lateral sclerosis. Int J Mol Sci. 2018;19(10):3137. doi: 10.3390/ijms19103137.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19103137</ArticleId><ArticleId IdType="pmc">PMC6213462</ArticleId><ArticleId IdType="pubmed">30322030</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao F-B, Almeida S, Lopez-Gonzalez R. Dysregulated molecular pathways in amyotrophic lateral sclerosis&#x2013;frontotemporal dementia spectrum disorder. EMBO J. 2017;36(20):2931&#x2013;2950. doi: 10.15252/embj.201797568.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201797568</ArticleId><ArticleId IdType="pmc">PMC5641681</ArticleId><ArticleId IdType="pubmed">28916614</ArticleId></ArticleIdList></Reference><Reference><Citation>Rass U, Ahel I, West SC. Defective DNA repair and neurodegenerative disease. Cell. 2007;130(6):991&#x2013;1004. doi: 10.1016/j.cell.2007.08.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2007.08.043</ArticleId><ArticleId IdType="pubmed">17889645</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciccia A, Elledge SJ. The DNA damage response: making it safe to play with knives. Mol Cell. 2010;40(2):179&#x2013;204. doi: 10.1016/j.molcel.2010.09.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2010.09.019</ArticleId><ArticleId IdType="pmc">PMC2988877</ArticleId><ArticleId IdType="pubmed">20965415</ArticleId></ArticleIdList></Reference><Reference><Citation>Welty S, Teng Y, Liang Z, et al. RAD52 is required for RNA-templated recombination repair in post-mitotic neurons. J Biol Chem. 2018;293(4):1353&#x2013;1362. doi: 10.1074/jbc.M117.808402.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M117.808402</ArticleId><ArticleId IdType="pmc">PMC5787811</ArticleId><ArticleId IdType="pubmed">29217771</ArticleId></ArticleIdList></Reference><Reference><Citation>Keskin H, Shen Y, Huang F, et al. Transcript-RNA-templated DNA recombination and repair. Nature. 2014;515(7527):436&#x2013;439. doi: 10.1038/nature13682.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature13682</ArticleId><ArticleId IdType="pmc">PMC4899968</ArticleId><ArticleId IdType="pubmed">25186730</ArticleId></ArticleIdList></Reference><Reference><Citation>McDevitt S, Rusanov T, Kent T, Chandramouly G, Pomerantz RT. How RNA transcripts coordinate DNA recombination and repair. Nat Commun. 2018;9(1):1091. doi: 10.1038/s41467-018-03483-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-03483-7</ArticleId><ArticleId IdType="pmc">PMC5854605</ArticleId><ArticleId IdType="pubmed">29545568</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasuhara T, Kato R, Hagiwara Y, et al. Human Rad52 Promotes XPG-Mediated R-loop Processing to Initiate Transcription-Associated Homologous Recombination Repair. Cell. 2018;175(2):558&#x2013;570.e511. doi: 10.1016/j.cell.2018.08.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.08.056</ArticleId><ArticleId IdType="pubmed">30245011</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunn A, Stark JM. I-SceI-based assays to examine distinct repair outcomes of mammalian chromosomal double Strand breaks. In: Bjergb&#xe6;k L, editor. DNA repair protocols. Totowa, NJ: Humana Press; 2012. pp. 379&#x2013;391.</Citation><ArticleIdList><ArticleId IdType="pubmed">22941618</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeier Z, Esanov R, Belle KC, et al. Bromodomain inhibitors regulate the C9ORF72 locus in ALS. Exp Neurol. 2015;271:241&#x2013;250. doi: 10.1016/j.expneurol.2015.06.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2015.06.017</ArticleId><ArticleId IdType="pmc">PMC4586400</ArticleId><ArticleId IdType="pubmed">26099177</ArticleId></ArticleIdList></Reference><Reference><Citation>Schindelin J, Arganda-Carreras I, Frise E, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9(7):676&#x2013;682. doi: 10.1038/nmeth.2019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.2019</ArticleId><ArticleId IdType="pmc">PMC3855844</ArticleId><ArticleId IdType="pubmed">22743772</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Majounie E, Waite A, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72(2):257&#x2013;268. doi: 10.1016/j.neuron.2011.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Esanov R, Belle KC, van Blitterswijk M, et al. C9orf72 promoter hypermethylation is reduced while hydroxymethylation is acquired during reprogramming of ALS patient cells. Exp Neurol. 2016;277:171&#x2013;177. doi: 10.1016/j.expneurol.2015.12.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2015.12.022</ArticleId><ArticleId IdType="pmc">PMC4761318</ArticleId><ArticleId IdType="pubmed">26746986</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartmann H, Hornburg D, Czuppa M, et al. Proteomics and C9orf72 neuropathology identify ribosomes as poly-GR/PR interactors driving toxicity. Life Sci Alliance. 2018;1(2):e201800070. doi: 10.26508/lsa.201800070.</Citation><ArticleIdList><ArticleId IdType="doi">10.26508/lsa.201800070</ArticleId><ArticleId IdType="pmc">PMC6238541</ArticleId><ArticleId IdType="pubmed">30456350</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitrea DM, Cika JA, Guy CS, et al. Nucleophosmin integrates within the nucleolus via multi-modal interactions with proteins displaying R-rich linear motifs and rRNA. Elife. 2016;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4786410</ArticleId><ArticleId IdType="pubmed">26836305</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitrea DM, Grace CR, Buljan M, et al. Structural polymorphism in the N-terminal oligomerization domain of NPM1. Proc Natl Acad Sci U S A. 2014;111(12):4466&#x2013;4471. doi: 10.1073/pnas.1321007111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1321007111</ArticleId><ArticleId IdType="pmc">PMC3970533</ArticleId><ArticleId IdType="pubmed">24616519</ArticleId></ArticleIdList></Reference><Reference><Citation>Farg MA, Konopka A, Soo KY, Ito D, Atkin JD. The DNA damage response (DDR) is induced by the C9orf72 repeat expansion in amyotrophic lateral sclerosis. Hum Mol Genet. 2017;26(15):2882&#x2013;2896. doi: 10.1093/hmg/ddx170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx170</ArticleId><ArticleId IdType="pubmed">28481984</ArticleId></ArticleIdList></Reference><Reference><Citation>Koike A, Nishikawa H, Wu W, Okada Y, Venkitaraman AR, Ohta T. Recruitment of phosphorylated NPM1 to sites of DNA damage through RNF8-dependent ubiquitin conjugates. Cancer Res. 2010;70(17):6746&#x2013;6756. doi: 10.1158/0008-5472.CAN-10-0382.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-10-0382</ArticleId><ArticleId IdType="pubmed">20713529</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu M-H, Lam C-Y, Yung BY-M. Translocation of nucleophosmin from the nucleoli to nucleoplasm requires ATP. Biochem J. 1995;305:5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1136355</ArticleId><ArticleId IdType="pubmed">7848301</ArticleId></ArticleIdList></Reference><Reference><Citation>Bates M, Huang B, Dempsey GT, Zhuang X. Multicolor super-resolution imaging with photo-switchable fluorescent probes. Science. 2007;317(5845):1749. doi: 10.1126/science.1146598.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1146598</ArticleId><ArticleId IdType="pmc">PMC2633025</ArticleId><ArticleId IdType="pubmed">17702910</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Zhang M, Li D, et al. Highly photostable, reversibly photoswitchable fluorescent protein with high contrast ratio for live-cell superresolution microscopy. Proc Natl Acad Sci. 2016;113(37):10364. doi: 10.1073/pnas.1611038113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1611038113</ArticleId><ArticleId IdType="pmc">PMC5027434</ArticleId><ArticleId IdType="pubmed">27562163</ArticleId></ArticleIdList></Reference><Reference><Citation>Honda M, Okuno Y, Yoo J, Ha T, Spies M. Tyrosine phosphorylation enhances RAD52-mediated annealing by modulating its DNA binding. EMBO J. 2011;30(16):3368&#x2013;3382. doi: 10.1038/emboj.2011.238.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2011.238</ArticleId><ArticleId IdType="pmc">PMC3160658</ArticleId><ArticleId IdType="pubmed">21804533</ArticleId></ArticleIdList></Reference><Reference><Citation>Symington LS. Role of RAD52 epistasis group genes in homologous recombination and double-Strand break repair. Microbiol Mol Biol Rev. 2002;66(4):630&#x2013;670. doi: 10.1128/MMBR.66.4.630-670.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MMBR.66.4.630-670.2002</ArticleId><ArticleId IdType="pmc">PMC134659</ArticleId><ArticleId IdType="pubmed">12456786</ArticleId></ArticleIdList></Reference><Reference><Citation>Esanov R, Cabrera GT, Andrade NS, et al. A C9ORF72 BAC mouse model recapitulates key epigenetic perturbations of ALS/FTD. Mol Neurodegener. 2017;12(1):46. doi: 10.1186/s13024-017-0185-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-017-0185-9</ArticleId><ArticleId IdType="pmc">PMC5468954</ArticleId><ArticleId IdType="pubmed">28606110</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker RG, Obeid J, Nguyen T, et al. Sedentary time and screen-based sedentary behaviors of children with a chronic disease. Pediatr Exerc Sci. 2015;27(2):219&#x2013;225. doi: 10.1123/pes.2014-0074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1123/pes.2014-0074</ArticleId><ArticleId IdType="pubmed">25389217</ArticleId></ArticleIdList></Reference><Reference><Citation>Russ J, Liu EY, Wu K, et al. Hypermethylation of repeat expanded C9orf72 is a clinical and molecular disease modifier. Acta Neuropathol. 2015;129(1):39&#x2013;52. doi: 10.1007/s00401-014-1365-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1365-0</ArticleId><ArticleId IdType="pmc">PMC4282973</ArticleId><ArticleId IdType="pubmed">25388784</ArticleId></ArticleIdList></Reference><Reference><Citation>Belzil VV, Bauer PO, Gendron TF, Murray ME, Dickson D, Petrucelli L. Characterization of DNA hypermethylation in the cerebellum of c9FTD/ALS patients. Brain Res. 2014;1584:15&#x2013;21. doi: 10.1016/j.brainres.2014.02.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2014.02.015</ArticleId><ArticleId IdType="pmc">PMC4130919</ArticleId><ArticleId IdType="pubmed">24530272</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Gould TD, Yuan P, Manji HK, Chen G. Post-mortem interval effects on the phosphorylation of signaling proteins. Neuropsychopharmacology. 2003;28(6):1017&#x2013;1025. doi: 10.1038/sj.npp.1300112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.npp.1300112</ArticleId><ArticleId IdType="pubmed">12637955</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Zhang Y, Hu W, et al. Rapid alteration of protein phosphorylation during postmortem: implication in the study of protein phosphorylation. Sci Rep. 2015;5:15709. doi: 10.1038/srep15709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep15709</ArticleId><ArticleId IdType="pmc">PMC4625177</ArticleId><ArticleId IdType="pubmed">26511732</ArticleId></ArticleIdList></Reference><Reference><Citation>Ash PE, Bieniek KF, Gendron TF, et al. Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS. Neuron. 2013;77(4):639&#x2013;646. doi: 10.1016/j.neuron.2013.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.02.004</ArticleId><ArticleId IdType="pmc">PMC3593233</ArticleId><ArticleId IdType="pubmed">23415312</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendron TF, Bieniek KF, Zhang YJ, et al. Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS. Acta Neuropathol. 2013;126(6):829&#x2013;844. doi: 10.1007/s00401-013-1192-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1192-8</ArticleId><ArticleId IdType="pmc">PMC3830741</ArticleId><ArticleId IdType="pubmed">24129584</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR, Arzberger T, Kremmer E, et al. Dipeptide repeat protein pathology in C9ORF72 mutation cases: clinico-pathological correlations. Acta Neuropathol. 2013;126(6):859&#x2013;879. doi: 10.1007/s00401-013-1181-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1181-y</ArticleId><ArticleId IdType="pubmed">24096617</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori K, Arzberger T, Grasser FA, et al. Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins. Acta Neuropathol. 2013;126(6):881&#x2013;893. doi: 10.1007/s00401-013-1189-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1189-3</ArticleId><ArticleId IdType="pubmed">24132570</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendron TF, van Blitterswijk M, Bieniek KF, et al. Cerebellar c9RAN proteins associate with clinical and neuropathological characteristics of C9ORF72 repeat expansion carriers. Acta Neuropathol. 2015;130(4):559&#x2013;573. doi: 10.1007/s00401-015-1474-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1474-4</ArticleId><ArticleId IdType="pmc">PMC4575385</ArticleId><ArticleId IdType="pubmed">26350237</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitra Joy, Guerrero Erika N., Hegde Pavana M., Liachko Nicole F., Wang Haibo, Vasquez Velmarini, Gao Junling, Pandey Arvind, Taylor J. Paul, Kraemer Brian C., Wu Ping, Boldogh Istvan, Garruto Ralph M., Mitra Sankar, Rao K. S., Hegde Muralidhar L. Motor neuron disease-associated loss of nuclear TDP-43 is linked to DNA double-strand break repair defects. Proceedings of the National Academy of Sciences. 2019;116(10):4696&#x2013;4705. doi: 10.1073/pnas.1818415116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1818415116</ArticleId><ArticleId IdType="pmc">PMC6410842</ArticleId><ArticleId IdType="pubmed">30770445</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Gonzalez R, Lu Y, Gendron TF, et al. Poly(GR) in C9ORF72-related ALS/FTD compromises mitochondrial function and increases oxidative stress and DNA damage in iPSC-derived motor neurons. Neuron. 2016;92(2):383&#x2013;391. doi: 10.1016/j.neuron.2016.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.09.015</ArticleId><ArticleId IdType="pmc">PMC5111366</ArticleId><ArticleId IdType="pubmed">27720481</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker C, El-Khamisy SF. Perturbed autophagy and DNA repair converge to promote neurodegeneration in amyotrophic lateral sclerosis and dementia. Brain. 2018.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5917746</ArticleId><ArticleId IdType="pubmed">29584802</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker C, Herranz-Martin S, Karyka E, et al. C9orf72 expansion disrupts ATM-mediated chromosomal break repair. Nat Neurosci. 2017;20(9):1225&#x2013;1235. doi: 10.1038/nn.4604.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4604</ArticleId><ArticleId IdType="pmc">PMC5578434</ArticleId><ArticleId IdType="pubmed">28714954</ArticleId></ArticleIdList></Reference><Reference><Citation>Madabhushi R, Pan L, Tsai LH. DNA damage and its links to neurodegeneration. Neuron. 2014;83(2):266&#x2013;282. doi: 10.1016/j.neuron.2014.06.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.06.034</ArticleId><ArticleId IdType="pmc">PMC5564444</ArticleId><ArticleId IdType="pubmed">25033177</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross CA, Poirier MA. Protein aggregation and neurodegenerative disease. Nat Med. 2004;10:S10. doi: 10.1038/nm1066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1066</ArticleId><ArticleId IdType="pubmed">15272267</ArticleId></ArticleIdList></Reference><Reference><Citation>Nihei Y, Mori K, Werner G, et al. Poly-glycine-alanine exacerbates C9orf72 repeat expansion-mediated DNA damage via sequestration of phosphorylated ATM and loss of nuclear hnRNPA3. Acta Neuropathol. 2019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6942035</ArticleId><ArticleId IdType="pubmed">31642962</ArticleId></ArticleIdList></Reference><Reference><Citation>Vatsavayai SC, Nana AL, Yokoyama JS, Seeley WW. C9orf72-FTD/ALS pathogenesis: evidence from human neuropathological studies. Acta Neuropathol. 2019;137(1):1&#x2013;26. doi: 10.1007/s00401-018-1921-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1921-0</ArticleId><ArticleId IdType="pmc">PMC6546170</ArticleId><ArticleId IdType="pubmed">30368547</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemay DG, Pollard KS, Martin WF, et al. From genes to milk: genomic organization and epigenetic regulation of the mammary transcriptome. PLoS One. 2013;8(9):e75030. doi: 10.1371/journal.pone.0075030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0075030</ArticleId><ArticleId IdType="pmc">PMC3784412</ArticleId><ArticleId IdType="pubmed">24086428</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, Budhu A, Forgues M, Wang XW. Temporal and spatial control of nucleophosmin by the ran-Crm1 complex in centrosome duplication. Nat Cell Biol. 2005;7(8):823&#x2013;830. doi: 10.1038/ncb1282.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb1282</ArticleId><ArticleId IdType="pubmed">16041368</ArticleId></ArticleIdList></Reference><Reference><Citation>Amin MA, Matsunaga S, Uchiyama S, Fukui K. Depletion of nucleophosmin leads to distortion of nucleolar and nuclear structures in HeLa cells. Biochem J. 2008;415(3):345&#x2013;351. doi: 10.1042/BJ20081411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20081411</ArticleId><ArticleId IdType="pmc">PMC2590675</ArticleId><ArticleId IdType="pubmed">18729828</ArticleId></ArticleIdList></Reference><Reference><Citation>Amin MA, Matsunaga S, Uchiyama S, Fukui K. Nucleophosmin is required for chromosome congression, proper mitotic spindle formation, and kinetochore-microtubule attachment in HeLa cells. FEBS Lett. 2008;582(27):3839&#x2013;3844. doi: 10.1016/j.febslet.2008.10.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2008.10.023</ArticleId><ArticleId IdType="pubmed">18951898</ArticleId></ArticleIdList></Reference><Reference><Citation>Tchurikov NA, Fedoseeva DM, Sosin DV, et al. Hot spots of DNA double-strand breaks and genomic contacts of human rDNA units are involved in epigenetic regulation. J Mol Cell Biol. 2015;7(4):366&#x2013;382. doi: 10.1093/jmcb/mju038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jmcb/mju038</ArticleId><ArticleId IdType="pmc">PMC4524424</ArticleId><ArticleId IdType="pubmed">25280477</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu MH, Yung BY. UV stimulation of nucleophosmin/B23 expression is an immediate-early gene response induced by damaged DNA. J Biol Chem. 2002;277(50):48234&#x2013;48240. doi: 10.1074/jbc.M206550200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M206550200</ArticleId><ArticleId IdType="pubmed">12374805</ArticleId></ArticleIdList></Reference><Reference><Citation>Sekhar KR, Benamar M, Venkateswaran A, et al. Targeting nucleophosmin 1 represents a rational strategy for radiation sensitization. Int J Radiat Oncol Biol Phys. 2014;89(5):1106&#x2013;1114. doi: 10.1016/j.ijrobp.2014.04.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijrobp.2014.04.012</ArticleId><ArticleId IdType="pmc">PMC4105849</ArticleId><ArticleId IdType="pubmed">25035215</ArticleId></ArticleIdList></Reference><Reference><Citation>Meder VS, Boeglin M, de Murcia G, Schreiber V. PARP-1 and PARP-2 interact with nucleophosmin/B23 and accumulate in transcriptionally active nucleoli. J Cell Sci. 2005;118(Pt 1):211&#x2013;222. doi: 10.1242/jcs.01606.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.01606</ArticleId><ArticleId IdType="pubmed">15615785</ArticleId></ArticleIdList></Reference><Reference><Citation>Acs K, Luijsterburg MS, Ackermann L, Salomons FA, Hoppe T, Dantuma NP. The AAA-ATPase VCP/p97 promotes 53BP1 recruitment by removing L3MBTL1 from DNA double-strand breaks. Nat Struct Mol Biol. 2011;18(12):1345&#x2013;1350. doi: 10.1038/nsmb.2188.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.2188</ArticleId><ArticleId IdType="pubmed">22120668</ArticleId></ArticleIdList></Reference><Reference><Citation>Meerang M, Ritz D, Paliwal S, et al. The ubiquitin-selective segregase VCP/p97 orchestrates the response to DNA double-strand breaks. Nat Cell Biol. 2011;13(11):1376&#x2013;1382. doi: 10.1038/ncb2367.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb2367</ArticleId><ArticleId IdType="pubmed">22020440</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Boom J, Wolf M, Weimann L, et al. VCP/p97 extracts Sterically trapped Ku70/80 rings from DNA in double-Strand break repair. Mol Cell. 2016;64(1):189&#x2013;198. doi: 10.1016/j.molcel.2016.08.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2016.08.037</ArticleId><ArticleId IdType="pmc">PMC5161236</ArticleId><ArticleId IdType="pubmed">27716483</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuetz AK, Kay LE. A dynamic molecular basis for malfunction in disease mutants of p97/VCP. Elife. 2016;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5102582</ArticleId><ArticleId IdType="pubmed">27828775</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang WY, Pan L, Su SC, et al. Interaction of FUS and HDAC1 regulates DNA damage response and repair in neurons. Nat Neurosci. 2013;16(10):1383&#x2013;1391. doi: 10.1038/nn.3514.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3514</ArticleId><ArticleId IdType="pmc">PMC5564396</ArticleId><ArticleId IdType="pubmed">24036913</ArticleId></ArticleIdList></Reference><Reference><Citation>Rulten SL, Rotheray A, Green RL, et al. PARP-1 dependent recruitment of the amyotrophic lateral sclerosis-associated protein FUS/TLS to sites of oxidative DNA damage. Nucleic Acids Res. 2014;42(1):307&#x2013;314. doi: 10.1093/nar/gkt835.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkt835</ArticleId><ArticleId IdType="pmc">PMC3874156</ArticleId><ArticleId IdType="pubmed">24049082</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill SJ, Mordes DA, Cameron LA, et al. Two familial ALS proteins function in prevention/repair of transcription-associated DNA damage. Proc Natl Acad Sci U S A. 2016;113(48):E7701&#x2013;E7709. doi: 10.1073/pnas.1611673113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1611673113</ArticleId><ArticleId IdType="pmc">PMC5137757</ArticleId><ArticleId IdType="pubmed">27849576</ArticleId></ArticleIdList></Reference><Reference><Citation>Dutertre M, Vagner S. DNA-damage response RNA-binding proteins (DDRBPs): perspectives from a new class of proteins and their RNA targets. J Mol Biol. 2017;429(21):3139&#x2013;3145. doi: 10.1016/j.jmb.2016.09.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2016.09.019</ArticleId><ArticleId IdType="pubmed">27693651</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato R, Miyagawa K, Yasuhara T. The role of R-loops in transcription-associated DNA double-strand break repair. Mol Cell Oncol. 2019;6(1):1542244. doi: 10.1080/23723556.2018.1542244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23723556.2018.1542244</ArticleId><ArticleId IdType="pmc">PMC6370373</ArticleId><ArticleId IdType="pubmed">30788418</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue C, Greene EC. New roles for RAD52 in DNA repair. Cell Res. 2018;28(12):1127&#x2013;1128. doi: 10.1038/s41422-018-0105-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-018-0105-8</ArticleId><ArticleId IdType="pmc">PMC6274643</ArticleId><ArticleId IdType="pubmed">30367126</ArticleId></ArticleIdList></Reference><Reference><Citation>Sollier J, Stork CT, Garcia-Rubio ML, Paulsen RD, Aguilera A, Cimprich KA. Transcription-coupled nucleotide excision repair factors promote R-loop-induced genome instability. Mol Cell. 2014;56(6):777&#x2013;785. doi: 10.1016/j.molcel.2014.10.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2014.10.020</ArticleId><ArticleId IdType="pmc">PMC4272638</ArticleId><ArticleId IdType="pubmed">25435140</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>